Illuminare Biotechnologies Overview
- Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
Illuminare Biotechnologies General Information
Description
Developer of intra-operative nerve visualization systems designed to reduce the risk of nerve damage. The company's candidate binds specifically to myelin and illuminates to make nerves, fat, muscles, and blood vessels more visible, helping surgeons with more improved visibility during operations.
Contact Information
Website
www.illuminarebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 327 Saint Marks Avenue
- Brooklyn, NY 11238
- United States
Illuminare Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Jan-2021 | 00.000 | Completed | Pre-Clinical Trials | ||
| 2. Early Stage VC | 17-Dec-2018 | Cancelled | Stealth | |||
| 1. Early Stage VC (Series A) | 18-Aug-2017 | $2.37M | $2.37M | 000.00 | Completed | Stealth |
Illuminare Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Illuminare Biotechnologies Executive Team (4)
Illuminare Biotechnologies Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Oliver Curme | Self | Board Member | 000 0000 |
| Robert Graifman | Self | Board Member | 000 0000 |
| Shay Grinfield | Illuminare Biotechnologies | Board Member | 000 0000 |
| Walter Greenblatt | Illuminare Biotechnologies | Chairman & Acting Chief Executive Officer | 000 0000 |
Illuminare Biotechnologies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Endo Investors | Venture Capital | Minority | 000 0000 | 000000 0 | |
| General Electric | Corporation | Minority | 000 0000 | 000000 0 | |
| Memorial Sloan Kettering Cancer Center | Corporation | Minority | 000 0000 | 000000 0 |